We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+6.5%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.6B
AUM Growth
+$570M
(+3.3%)
Cap. Flow
-$224M
Cap. Flow
% of AUM
-1.27%
Top 10 Holdings %
Top 10 Hldgs %
20.72%
Holding
1,372
New
93
Increased
502
Reduced
569
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$54.9M |
| 2 |
Accenture
ACN
|
+$54.6M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$36.3M |
| 4 |
Gartner
IT
|
+$35.8M |
| 5 |
Humana
HUM
|
+$32.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$61.7M |
| 2 |
Danaher
DHR
|
+$38.4M |
| 3 |
Progressive
PGR
|
+$36.4M |
| 4 |
Automatic Data Processing
ADP
|
+$33.9M |
| 5 |
Paychex
PAYX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.97% |
| 2 | Healthcare | 12.8% |
| 3 | Financials | 9.66% |
| 4 | Consumer Discretionary | 8.95% |
| 5 | Industrials | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Princeton Bancorp
BPRN
$283M
| $626K | ﹤0.01% |
19,725
+650
| +3% | +$21.8K |
|
777
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.74B
| $625K | ﹤0.01% |
18,985
-130
| -0.7% | -$4.37K |
|
778
Element Solutions
ESI
$8.48B
| $624K | ﹤0.01% |
32,338
-302
| -0.9% | -$5.96K |
|
779
VeriSign
VRSN
$26.3B
| $622K | ﹤0.01% |
2,941
+6
| +0.2% | +$1.24K |
|
780
HCA Healthcare
HCA
$88.4B
| $621K | ﹤0.01% |
2,355
+74
| +3% | +$18.8K |
|
|
DCP
781
DELISTED
DCP Midstream, LP
DCP
| $617K | ﹤0.01% |
14,790
-38,772
| -72% | -$1.61M |
|
|
MODN
782
DELISTED
MODEL N, INC.
MODN
| $617K | ﹤0.01% |
18,431
-207
| -1% | -$7.55K |
|
783
Supernus Pharmaceuticals
SUPN
$2.7B
| $614K | ﹤0.01% |
16,946
+1,123
| +7% | +$43.2K |
|
784
Lamar Advertising Co
LAMR
$16.7B
| $614K | ﹤0.01% |
6,143
-244,582
| -98% | -$24.8M |
|
785
Vanguard Industrials ETF
VIS
$7.94B
| $611K | ﹤0.01% |
3,208
-92
| -3% | -$17.5K |
|
786
Cal-Maine
CALM
$4.43B
| $610K | ﹤0.01% |
10,026
+2,773
| +38% | +$155K |
|
787
Dentsply Sirona
XRAY
$2.84B
| $609K | ﹤0.01% |
15,507
-607
| -4% | -$22.3K |
|
788
e.l.f. Beauty
ELF
$4.77B
| $608K | ﹤0.01% |
+7,380
| New | +$497K |
|
789
DexCom
DXCM
$29B
| $597K | ﹤0.01% |
5,138
+747
| +17% | +$83.6K |
|
790
Helen of Troy
HELE
$656M
| $597K | ﹤0.01% |
6,272
-2,976
| -32% | -$319K |
|
791
Constellation Brands
STZ
$22.5B
| $597K | ﹤0.01% |
2,642
-541
| -17% | -$120K |
|
792
SiteOne Landscape Supply
SITE
$4.09B
| $593K | ﹤0.01% |
4,336
-55
| -1% | -$7.75K |
|
|
RETA
793
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $591K | ﹤0.01% |
+6,502
| New | +$382K |
|
794
Hexcel
HXL
$7.97B
| $591K | ﹤0.01% |
8,660
-1,367
| -14% | -$92.7K |
|
795
Molson Coors Class B
TAP
$8.02B
| $589K | ﹤0.01% |
11,398
+5,338
| +88% | +$276K |
|
796
NNN REIT
NNN
$9.29B
| $589K | ﹤0.01% |
13,339
+440
| +3% | +$20K |
|
797
Ball Corp
BALL
$17.5B
| $589K | ﹤0.01% |
10,685
+3,906
| +58% | +$217K |
|
798
Commerce Bancshares
CBSH
$8.68B
| $586K | ﹤0.01% |
11,624
+1,261
| +12% | +$70.4K |
|
799
Schneider National
SNDR
$6.17B
| $586K | ﹤0.01% |
+21,890
| New | +$590K |
|
800
Kilroy Realty
KRC
$4.59B
| $577K | ﹤0.01% |
17,806
+10,513
| +144% | +$383K |
|
Similar funds
EWA
MIC
P
OSAM
CB
EIM
SC
Glenmede Trust's Q1 2023 Portfolio in Review
As of Q1 2023, Glenmede Trust held 1,372 positions worth $17.6B, up 3.3% from $17B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Glenmede Trust's Q1 2023 filing shows 93 new, 502 increased, 569 reduced and 82 closed positions. Its largest new stake was Zoom: 177,014 shares worth $13.1M. The largest sale was Advanced Micro Devices, an estimated $61.7M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Glenmede Trust's largest Q1 2023 buy was Zoom: 177,014 shares worth $13.1M.
- Glenmede Trust added most to Procter & Gamble in Q1 2023, an estimated $54.9M increase.
- Glenmede Trust's biggest Q1 2023 reduction was Advanced Micro Devices, cutting an estimated $61.7M.
- Glenmede Trust fully exited Matador Resources in Q1 2023, selling an estimated $17.9M.
- Glenmede Trust's ten largest holdings make up 21% of its $17.6B portfolio in Q1 2023.
- Glenmede Trust opened 93 new positions and closed 82 in Q1 2023.
- Glenmede Trust's portfolio value rose 3.3% quarter-over-quarter to $17.6B.
Based on Glenmede Trust's 13F filing for Q1 2023, filed 15 May 2023.